德尔塔
您当前所在位置:首页 > 分析科学 > 新品上市

「同位素标记抑制剂」CAS:350818-67-6|Rimantadine-d4 hydrochloride

发布时间:2025-06-13     作者:德尔塔生物   分享到:

【产品介绍】:

生物活性:Rimantadine-d4 (hydrochloride) is the deuterium labeled Rimantadine hydrochloride. Rimantadine is an orally active inhibitor for M2 protein, that blocks the hydrogen ion channel activity, prevents the entry and replication of the virus, and exhibits board-spectrum antiviral activity[1].
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
Rimantadine-d4 hydrochloride 相关抗体:
Poliovirus Receptor Antibody (YA2556)
分子量:219.79
Formula:C12H18D4ClN
CAS 号:350818-67-6
非标记 CAS:1501-84-4
性状:固体
颜色:White to off-white
中文名称:金刚乙胺-d4
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years
In solvent:-80°C:6 months,-20°C:1 month
纯度 & 产品资料
纯度: ≥99.0%
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
 [Content Brief]
[2]. Tominack, R.L. and F.G. Hayden, Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am, 1987. 1(2): p. 459-78.
 [Content Brief]
[3]. Hall, C.B., et al., Children with influenza A infection: treatment with rimantadine. Pediatrics, 1987. 80(2): p. 275-82.
 [Content Brief]